Comparative Efficacy of Saroglitazar and Pioglitazone in Nonalcoholic Fatty Liver Disease Patients: A Bayesian Network Meta-analysis

Background and Aims: Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome. Two drugs, saroglitazar (S) and pioglitazone (P), are known to have beneficial effects on metabolic syndrome. This Bayesian network meta-analysis (NMA) was conducted to compare the relative efficacy...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Binayak Sinha, Samit Ghosal, Debasis Datta
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Medknow Publications 2024-01-01
Colecção:	International Journal of Diabetes and Technology
Assuntos:	nonalcoholic fatty liver disease network meta-analysis pioglitazone saroglitazar surface under the cumulative ranking curve
Acesso em linha:	https://journals.lww.com/10.4103/ijdt.ijdt_10_24
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!